Name: Pro Medicus (PME) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

PME

Health Care Equipment & Services

Pro Medicus

Short interest: 4.03%; −0.31 pp 30d; as of 8 Oct 2026
Reported shorts: 4.2M
Shares on issue: 104.470M

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

About Pro Medicus

Pro Medicus is a leading provider of radiology information systems (RIS), Picture Archiving and Communication Systems (PACS), and advanced visualization solutions. The company's products combine speed, scalability, stability, and smarts to enhance and streamline medical practice management, optimizing efficiency for clinical and administrative staff.

Company profile →

Pro Medicus (ASX:PME) has 4.03% of its shares on issue reported as short positions as of 8 Oct 2026, or about 4,210,433 shares. Over the past 30 days that figure has fallen 0.31 percentage points, and over 90 days it has fallen 0.87 percentage points. Its highest recorded short interest was 5.46% in October 2020. PME is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.

Strategy fit

How each stock picker strategy reads PME today

Zanger BreakoutWatchScore 35rank 334 of 1942
CAN SLIMWatchScore 56rank 17 of 1541
Minervini Trend TemplateWatchScore 29rank 594 of 1716
Crowded-Short BreakoutWatchScore 25rank 180 of 1502
Quality compoundersWatchScore 80rank 28 of 1669

Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

PME fundamentals

In the year to 30 Jun 2026, Pro Medicus (ASX:PME) recorded revenue of A$261.6M and net profit after tax of A$265.3M. A year earlier it recorded revenue of A$212.9M and net profit after tax of A$115.2M. Year-on-year growth: revenue +22.9% (FY), EPS +130.3% (TTM). Net margin 101.4%, return on equity 75.0% (FY). Figures are in AUD, the company's reporting currency; source: Yahoo Finance, as at 14 Oct 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →